AI in clinical practice: positive outcomes dominate but questions linger, study finds

The clinical relevance of AI.

Sentynl acquires Eiger’s Zokinvy for progeria treatment

The therapy is indicated for treating Hutchinson-Gilford Progeria Syndrome and processing-deficient progeroid laminopathies. Credit: LeviaUA / Shutterstock.com. Zydus Lifesciences subsidiary Sentynl Therapeutics has announced the

May 6, 2024

Teladoc Health & Microsoft Expands Generative AI Integration

What You Should Know: – Teladoc Health today announced an integration expansion with Microsoft, leveraging AI to help minimize administrative burden and identify potential hazards.

July 19, 2023

Tech in Diabetes: What’s Going Wrong?

ORLANDO — Technologic advances aren’t fulfilling their promise for improving diabetes or overall health outcomes in the U.S., argued FDA Commissioner Robert Califf, MD. “We

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.